Some Long Covid claims are starting to emerge in certain life insurance morbidity product claims, particularly disability income in the US, with more widespread claims likely to follow. This is according to a Sector Comment published this week by Moody’s Investors Service.
It says, elevated death benefits aside, most of the costs of Covid are medical and will be picked up by global health insurance regimes.
Although the study of long COVID is still in its early days, the virus' credit impact on global life insurers it likely to be limited, given the insurers' business diversity and the flexibility embedded in the products themselves.
After experiencing Covid-19, some survivors continue to suffer from the virus' physical, neurological and cognitive effects, known collectively as Long Covid (or Long-haul Covid or Long term Covid), long after the virus itself recedes.
See the March-April issue of CIR Magazine for more on Long Covid, and on the likelihood of claims in the workplace.
Printed Copy:
Would you also like to receive CIR Magazine in print?
Data Use:
We will also send you our free daily email newsletters and other relevant communications, which you can opt out of at any time. Thank you.
YOU MIGHT ALSO LIKE